Literature DB >> 33390803

Clinical characteristics and follow-up analysis of 324 discharged COVID-19 patients in Shenzhen during the recovery period.

Han-Qing Liu1, Bo Yuan2, Ya-Wen An1, Kai-Jing Chen3, Qi Hu4, Xiao-Peng Hu1, Jia Zhao1, Yu Dong5, Yong-Xin Chen5, Wei-Xin Li5, Chang-Qing Sun6, Jian-Chun Wang1, Cheng Wang4, Shuo Song1.   

Abstract

Objectives: Research on recovering COVID-19 patients could be helpful for containing the pandemic and developing vaccines, but we still do not know much about the clinical features, recovery process, and antibody reactions during the recovery period.
Methods: We retrospectively analysed the epidemiological information, discharge summaries, and laboratory results of 324 patients.
Results: In all, 15 (8.62%) patients experienced chest distress/breath shortness, where 8 of the 15 were severely ill. This means severely ill patients need an extended amount of time to recover after discharge; next, 20 (11.49%) patients experienced anxiety and 21 (12.07%) had headache/insomnia and a small fraction of them complained of anosmia/ageusia, indicating that these patients need treatment for mental and psychological health issues. Regarding the re-positive patients, their CT and laboratory test results showed no obvious evidence of illness progress or infectivity but a high anti-SARS-CoV-2 antibody expression.
Conclusion: Recovered COVID-19 patients need psychological and physiological care and treatment, re-positivity can occur in any person, but juveniles, females, and patients with mild/moderate existing symptoms have higher rates of re-positivity, While there is no evidence that turning re-positive has an impact on their infectivity, but it still alerted us that we need differentiate them in the following managements. © The author(s).

Entities:  

Keywords:  Covid-19; antibody; epidemiology; vaccine

Year:  2021        PMID: 33390803      PMCID: PMC7757147          DOI: 10.7150/ijms.50873

Source DB:  PubMed          Journal:  Int J Med Sci        ISSN: 1449-1907            Impact factor:   3.738


  11 in total

1.  Effect of internet-delivered cognitive behavioral therapy on insomnia in convalescent patients with COVID-19: Protocol for a systematic review and meta-analysis.

Authors:  Yan Chen; Xiang Zhou; Jie Liu; Rui Li; Zihan Jiang; Lina Wang; Shuya Wang; Bo Li
Journal:  PLoS One       Date:  2022-06-14       Impact factor: 3.752

2.  Clinical and Gene Features of SARS-CoV-2-Positive Recurrence in Patients Recovered From COVID-19.

Authors:  Yuying Peng; Shaoqi Wang; Ruihuan Chai; Yong Chen; Nan Li; Boning Zeng; Qian Tang; Kai Zheng; Youfang Liang; Shouxia Xie; Wei Huang; Shaoxiang Wang; Xiao Wang
Journal:  Front Mol Biosci       Date:  2022-06-08

3.  Long-Term Follow-Up Study of COVID-19: Evaluation on Thin-Slice CT.

Authors:  Chun-Shuang Guan; Zhi-Juan Liu; Yan-Ni Du; Ru-Ming Xie; Bu-Dong Chen; Hui Chen; Yan Bai; Zhi-Bin Lv; Yan-Li Xu
Journal:  Infect Drug Resist       Date:  2022-10-18       Impact factor: 4.177

Review 4.  Overview of sleep management during COVID-19.

Authors:  Philip M Becker
Journal:  Sleep Med       Date:  2021-04-24       Impact factor: 4.842

Review 5.  Value of anal swabs for SARS-COV-2 detection: a literature review.

Authors:  Yuliang Wang; Xiaobo Chen; Feng Wang; Jie Geng; Bingxu Liu; Feng Han
Journal:  Int J Med Sci       Date:  2021-04-16       Impact factor: 3.738

6.  Immunoglobulin Response and Prognostic Factors in Repeated SARS-CoV-2 Positive Patients: A Systematic Review and Meta-Analysis.

Authors:  Fanni Dembrovszky; Szilárd Váncsa; Nelli Farkas; Bálint Erőss; Lajos Szakó; Brigitta Teutsch; Stefania Bunduc; Rita Nagy; Dóra Dohos; Szabolcs Kiss; Andrea Párniczky; Zsófia Vinkó; Zoltán Péterfi; Péter Hegyi
Journal:  Viruses       Date:  2021-04-30       Impact factor: 5.048

7.  A Mid-to-Long Term Comprehensive Evaluation of Psychological Distress and Erectile Function in COVID-19 Recovered Patients.

Authors:  Bintao Hu; Yajun Ruan; Kang Liu; Xian Wei; Yue Wu; Huan Feng; Zhiyao Deng; Jihong Liu; Tao Wang
Journal:  J Sex Med       Date:  2021-08-26       Impact factor: 3.937

8.  Clinical characteristics and impacts of traditional Chinese medicine treatment on the convalescents of COVID-19.

Authors:  Ya-Wen An; Bo Yuan; Jian-Chun Wang; Cheng Wang; Ting-Ting Liu; Shuo Song; Han-Qing Liu
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

Review 9.  Reinfection or Reactivation of Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review.

Authors:  Xiujuan Tang; Salihu S Musa; Shi Zhao; Daihai He
Journal:  Front Public Health       Date:  2021-06-11

10.  Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study.

Authors:  Carl H Göbel; Axel Heinze; Sarah Karstedt; Mascha Morscheck; Lilian Tashiro; Anna Cirkel; Qutyaba Hamid; Rabih Halwani; Mohamad-Hani Temsah; Malte Ziemann; Siegfried Görg; Thomas Münte; Hartmut Göbel
Journal:  Pain Ther       Date:  2021-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.